BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28261781)

  • 1. Cognitive impairment and hippocampal atrophy in chronic kidney disease.
    Chang CY; Lin CC; Tsai CF; Yang WC; Wang SJ; Lin FH; Fuh JL
    Acta Neurol Scand; 2017 Nov; 136(5):477-485. PubMed ID: 28261781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Magnetic Resonance Imaging Findings in Children and Young Adults With CKD.
    Hartung EA; Erus G; Jawad AF; Laney N; Doshi JJ; Hooper SR; Radcliffe J; Davatzikos C; Furth SL
    Am J Kidney Dis; 2018 Sep; 72(3):349-359. PubMed ID: 29398180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
    Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J;
    Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not.
    Spilling CA; Jones PW; Dodd JW; Barrick TR
    BMC Pulm Med; 2017 Jun; 17(1):92. PubMed ID: 28629404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
    Ben Assayag E; Eldor R; Korczyn AD; Kliper E; Shenhar-Tsarfaty S; Tene O; Molad J; Shapira I; Berliner S; Volfson V; Shopin L; Strauss Y; Hallevi H; Bornstein NM; Auriel E
    Stroke; 2017 Sep; 48(9):2368-2374. PubMed ID: 28801477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter volume and white matter lesions in chronic kidney disease: exploring the association with depressive symptoms.
    Meurs M; Roest AM; Groenewold NA; Franssen CF; Westerhuis R; Kloppenburg WD; Doornbos B; Beukema L; Lindmäe H; de Groot JC; van Tol MJ; de Jonge P
    Gen Hosp Psychiatry; 2016; 40():18-24. PubMed ID: 27040607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome.
    Diker S; Has AC; Kurne A; Göçmen R; Oğuz KK; Karabudak R
    Mult Scler Relat Disord; 2016 Nov; 10():14-21. PubMed ID: 27919482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
    Damjanovic D; Valsasina P; Rocca MA; Stromillo ML; Gallo A; Enzinger C; Hulst HE; Rovira A; Muhlert N; De Stefano N; Bisecco A; Fazekas F; Arévalo MJ; Yousry TA; Filippi M
    AJNR Am J Neuroradiol; 2017 Jan; 38(1):18-24. PubMed ID: 27686487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study.
    Vemuri P; Knopman DS; Jack CR; Lundt ES; Weigand SD; Zuk SM; Thostenson KB; Reid RI; Kantarci K; Slinin Y; Lakshminarayan K; Davey CS; Murray A
    J Alzheimers Dis; 2017; 55(3):1069-1082. PubMed ID: 27767995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of brain white matter lesions and atrophy with cognitive function in chronic kidney disease.
    Yeh YC; Kuo YT; Huang MF; Hwang SJ; Tsai JC; Kuo MC; Chen CS
    Int J Geriatr Psychiatry; 2019 Dec; 34(12):1826-1832. PubMed ID: 31418471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Kidney Disease and Subclinical Brain Infarction Increase the Risk of Vascular Cognitive Impairment: The Sefuri Study.
    Yao H; Araki Y; Takashima Y; Uchino A; Yuzuriha T; Hashimoto M
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):420-424. PubMed ID: 28341210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.
    Murea M; Hsu FC; Cox AJ; Hugenschmidt CE; Xu J; Adams JN; Raffield LM; Whitlow CT; Maldjian JA; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2015 Aug; 30(8):1322-9. PubMed ID: 25722384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.
    Tsuruya K; Yoshida H; Haruyama N; Fujisaki K; Hirakata H; Kitazono T
    PLoS One; 2015; 10(12):e0143706. PubMed ID: 26632813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral patterns of neuropsychological disturbances in hepatitis C patients.
    Prell T; Dirks M; Arvanitis D; Braun D; Peschel T; Worthmann H; Schuppner R; Raab P; Grosskreutz J; Weissenborn K
    J Neurovirol; 2019 Apr; 25(2):229-238. PubMed ID: 30610739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.
    Murray AM; Bell EJ; Tupper DE; Davey CS; Pederson SL; Amiot EM; Miley KM; McPherson L; Heubner BM; Gilbertson DT; Foley RN; Drawz PE; Slinin Y; Rossom RC; Lakshminarayan K; Vemuri P; Jack CR; Knopman DS
    Am J Kidney Dis; 2016 Apr; 67(4):593-600. PubMed ID: 26744128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay between gray matter and white matter neurodegeneration in subjective cognitive decline.
    Cedres N; Diaz-Galvan P; Diaz-Flores L; Muehlboeck JS; Molina Y; Barroso J; Westman E; Ferreira D
    Aging (Albany NY); 2021 Aug; 13(16):19963-19977. PubMed ID: 34433132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population.
    Chen CH; Chen YF; Chiu MJ; Chen TF; Tsai PH; Chen JH; Yen CJ; Tang SC; Yeh SJ; Chen YC
    Sci Rep; 2017 May; 7(1):2337. PubMed ID: 28539636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Associations of Diastolic and Systolic Pressures With Cerebral Measures in Older Individuals With Mild Cognitive Impairment.
    Shokouhi M; Qiu D; Samman Tahhan A; Quyyumi AA; Hajjar I
    Am J Hypertens; 2018 Nov; 31(12):1268-1277. PubMed ID: 30052724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.